Your browser doesn't support javascript.
loading
Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome.
Patjamontri, Supitcha; Lucas-Herald, Angela K; Bryce, Jillian; van den Akker, Erica; Cools, Martine; Globa, Evgenia; Guerra-Junior, Gil; Hiort, Olaf; Hofman, Paul; Holterhus, Paul-Martin; Hughes, Ieuan A; Juul, Anders; Nordenstrom, Anna; Russo, Gianni; Stancampiano, Marianna R; Seneviratne, Sumudu N; Tadokoro-Cuccaro, Rieko; Thankamony, Ajay; Weintrob, Naomi; Zelinska, Natalia; Ahmed, S Faisal.
Afiliación
  • Patjamontri S; Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, UK.
  • Lucas-Herald AK; Division of Endocrinology and Metabolism, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Bryce J; Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, UK.
  • van den Akker E; Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow G51 4TF, UK.
  • Cools M; Division of Pediatric Endocrinology, Department of Pediatrics, Sophia Children's Hospital and Center of Expertise DSD, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands.
  • Globa E; Department of Paediatric Endocrinology, Ghent University Hospital, University of Ghent, Ghent 9000, Belgium.
  • Guerra-Junior G; Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv 01021, Ukraine.
  • Hiort O; Interdisciplinary Group for the Study of Sex Determination and Differentiation, School of Medical Sciences (FCM), State University of Campinas, Campinas 13083-887, Brazil.
  • Hofman P; Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Lübeck, 23538 Lübeck, Germany.
  • Holterhus PM; Liggins Institute, University of Auckland, 1023 Auckland, New Zealand.
  • Hughes IA; Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University Hospital of Schleswig-Holstein, Campus Kiel/Christian-Albrechts University of Kiel, 24105 Kiel, Germany.
  • Juul A; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Nordenstrom A; Growth and Reproduction Rigshospitalet, University of Copenhagen, DK-2100 Copenhagen, Denmark.
  • Russo G; Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Stancampiano MR; Department of Pediatrics, Endocrine Unit, Scientific Institute San Raffaele, Milan 20132, Italy.
  • Seneviratne SN; Department of Pediatrics, Endocrine Unit, Scientific Institute San Raffaele, Milan 20132, Italy.
  • Tadokoro-Cuccaro R; Faculty of Medicine, University of Colombo, Colombo 8, Sri Lanka.
  • Thankamony A; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Weintrob N; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Zelinska N; Endocrinology and Diabetes Unit, Dana-Dwek Children's Hospital, Tel Aviv 6423906, Israel.
  • Ahmed SF; Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv 01021, Ukraine.
Article en En | MEDLINE | ID: mdl-39213311
ABSTRACT

INTRODUCTION:

Partial androgen insensitivity syndrome (PAIS) is a rare condition that is reported to be commonly associated with gynecomastia in males.

OBJECTIVES:

To assess the management of gynecomastia in male PAIS. MATERIALS AND

METHODS:

Retrospective review of males with PAIS over the age of 10 years in the I-DSD registry.

RESULTS:

Of the 205 eligible cases, information was available for 57 from 13 centers. An androgen receptor gene variant was confirmed in 45 (79%) with a median age at first presentation of 1.0 year (range 0.1, 26.0). Of the 45 genetically confirmed cases, gynecomastia was present in 41 (91%) with a median age at the time of gynecomastia development of 13.5 years (11.0, 29.0). In the other 4 (9%) with no gynecomastia, the median age at last assessment was 15.7 years (10.6, 17.0). In 30 cases with information available, micropenis was present at the time of gynecomastia development in 23 (77%). Of the 35 with information available, 2 (6%) exhibited spontaneous resolution between the ages of 15 and 21 years and 25 (71%) had breast surgery at a median age of 15.7 years (14.0, 23.0). Of these 25, 9 (26%) had previously received medical therapy. The median clinician score of effectiveness for medical therapy was 3 (1, 8) compared to 10 (3, 10) for surgery (P < .0001). In 31 with information available, 13 (42%) had received psychology support.

CONCLUSION:

Gynecomastia is common in PAIS but not universal. Surgical management may be more effective than medical therapy, but there is a need for further standardized and systematic studies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Endocrinol Metab Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Clin Endocrinol Metab Año: 2024 Tipo del documento: Article